Key Market Indicators
Korean antirheumatic medicine sales are predicted to reach nearly $721 million by 2026. In 2021, the Korean market was valued at $677 million, representing a year-on-year growth of 1.3%. Since 2013, the market has grown an average of 5.6% annually. Germany, Spain and Canada are the next largest markets in the ranking.
